Proposed NSAID package insert labeling
- PMID: 16687359
Proposed NSAID package insert labeling
Abstract
The United States Food and Drug Administration (FDA) has proposed new label warnings for all nonsteroidal anti-inflammatory drugs (NSAIDs) to warn about potential cardiovascular and other toxicities associated with these medications. The proposed label requirements are presented.